Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Clinical Subtype | Transcriptional Subtype | Small Molecule | Antibody | Perturbagen Target | Perturbagen Class | Perturbagen Concentration | Perturbagen Conc Unit | Biological Replicate ID | Relative Cell Count | Normalized Growth Rate Inhibition Value | Nominal Division Rate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ZR75B | HR+ | Luminal | Doxorubicin | TOP2 | TOP | 0.000236 | uM | 9997.121 | 1.1243 | 1.2222 | 1.1121 | |
| ZR75B | HR+ | Luminal | CPT-11 | TOP1 | TOP | 85.2 | uM | 9997.121 | 0.6581 | 0.3728 | 1.1121 | |
| ZR75B | HR+ | Luminal | Doxorubicin | TOP2 | TOP | 3.68 | uM | 9997.121 | 0.1652 | -0.6039 | 1.1121 | |
| ZR75B | HR+ | Luminal | CPT-11 | TOP1 | TOP | 0.00546 | uM | 9997.121 | 1.0316 | 1.0567 | 1.1121 | |
| ZR75B | HR+ | Luminal | Doxorubicin | TOP2 | TOP | 0.00589 | uM | 9997.121 | 1.0363 | 1.0651 | 1.1121 | |
| ZR75B | HR+ | Luminal | CPT-11 | TOP1 | TOP | 0.00109 | uM | 9997.121 | 1.0633 | 1.1135 | 1.1121 | |
| ZR75B | HR+ | Luminal | Doxorubicin | TOP2 | TOP | 0.00118 | uM | 9997.121 | 1.0273 | 1.0491 | 1.1121 |